Aubagio
$840.00
AUBAGIO® (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Aubagio contains the active ingredient teriflunomide, a substance that acts on the immune system to limit it from attacking the nervous system. Aubagio is intended for the treatment of adults with relapsing-remitting multiple sclerosis, in order to reduce the frequency of relapses and to delay the progression of physical disability.
Brand Manufacturer: Sanofi
Indication: Aubagio is intended for the treatment of adults with relapsing-remitting multiple sclerosis, in order to reduce the frequency of relapses and to delay the progression of physical disability.